Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1677747

Cover Image

PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1677747

Sample Preparation Market Growth, Size, Trends Analysis - By Product, By Technique, By Application, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

PUBLISHED:
PAGES: 259 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Group License)
USD 5650
PDF (Company License)
USD 7450

Add to Cart

Sample Preparation Market Introduction and Overview

According to SPER market research, 'Global Sample Preparation Market Size- By Product, By Technique, By Application, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Sample Preparation Market is predicted to reach 14.81 billion by 2034 with a CAGR of 6.39%.

Sample preparation is the process of converting a biological sample, such as blood or urine, into an appropriate form for analysis using laboratory instruments, which is critical for accurate diagnosis and disease monitoring by isolating and purifying the target components in the sample prior to testing. This procedure has numerous uses in the healthcare business, including clinical diagnostics, pharmacokinetic investigations, genetic testing, microbiological testing, and forensic analysis.

Restraints: The initial expenditure necessary for improved sample preparation techniques and equipment might be a substantial barrier for some laboratories, especially those with limited budgets. While these technologies provide long-term productivity improvements and higher data quality, the initial expenses may dissuade smaller research centers from implementing cutting-edge sample preparation options. This financial barrier may hinder the general adoption of new approaches, particularly in resource-constrained environments.

Scope of the Report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Product, By Technique, By Application, By End User.

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.

Companies Covered

Merck KGaA, Thermo Fisher Scientific Inc, Bio-RAD Laboratories Inc, Tecan Group Ltd, Agilent Technologies Inc, Hamilton Company, Promega Corporation, Illumina Inc, Roche Applied Science, Danaher Corporation, Qiagen N.V. and others.

Sample Preparation Market Segmentation:

By Product: Based on the Product, Global Sample Preparation Market is segmented as; Instruments, Consumable, Kits.

By Technique: Based on the Technique, Global Sample Preparation Market is segmented as; Protein Preparation, Solid-phase extraction, Liquid-liquid extraction.

By Application: Based on the Application, Global Sample Preparation Market is segmented as; Genomics, Proteomics, Epigenomics, Transcriptomics, Metabolomics, Others.

By End User: Based on the End User, Global Sample Preparation Market is segmented as; Hospitals, Diagnostic Centers, Pharmaceutical and Biotechnology Industry, Others.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa

Product Code: HLCA2563

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPERs internal database
    • 2.1.4. Premium insight from KOLs
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTERs Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Global Sample Preparation Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Sample Preparation Market

7. Global Sample Preparation Market, By Product (USD Million) 2021-2034

  • 7.1. Instruments
    • 7.1.1. Extraction System
    • 7.1.2. Workstation
    • 7.1.3. Automated Evaporation System
    • 7.1.4. Liquid Handling Instrument
    • 7.1.5. Liquid handling workstations
    • 7.1.6. Pipetting systems
    • 7.1.7. Reagents dispensers
    • 7.1.8. Microplate washer
    • 7.1.9. Other liquid handling systems
  • 7.2. Consumable
  • 7.3. Kits
    • 7.3.1. Purification Kit
    • 7.3.2. Isolation Kit
    • 7.3.3. Extraction Kit

8. Global Sample Preparation Market, By Technique (USD Million) 2021-2034

  • 8.1. Protein Preparation
  • 8.2. Solid-phase extraction
  • 8.3. Liquid-liquid extraction

9. Global Sample Preparation Market, By Application (USD Million) 2021-2034

  • 9.1. Genomics
  • 9.2. Proteomics
  • 9.3. Epigenomics
  • 9.4. Transcriptomics
  • 9.5. Metabolomics
  • 9.6. Others

10. Global Sample Preparation Market, By End User (USD Million) 2021-2034

  • 10.1. Hospitals
  • 10.2. Diagnostic Centers
  • 10.3. Pharmaceutical and Biotechnology Industry
  • 10.4. Others

11. Global Sample Preparation Market, (USD Million) 2021-2034

  • 11.1. Global Sample Preparation Market Size and Market Share

12. Global Sample Preparation Market, By Region, (USD Million) 2021-2034

  • 12.1. Asia-Pacific
    • 12.1.1. Australia
    • 12.1.2. China
    • 12.1.3. India
    • 12.1.4. Japan
    • 12.1.5. South Korea
    • 12.1.6. Rest of Asia-Pacific
  • 12.2. Europe
    • 12.2.1. France
    • 12.2.2. Germany
    • 12.2.3. Italy
    • 12.2.4. Spain
    • 12.2.5. United Kingdom
    • 12.2.6. Rest of Europe
  • 12.3. Middle East and Africa
    • 12.3.1. Kingdom of Saudi Arabia
    • 12.3.2. United Arab Emirates
    • 12.3.3. Qatar
    • 12.3.4. South Africa
    • 12.3.5. Egypt
    • 12.3.6. Morocco
    • 12.3.7. Nigeria
    • 12.3.8. Rest of Middle-East and Africa
  • 12.4. North America
    • 12.4.1. Canada
    • 12.4.2. Mexico
    • 12.4.3. United States
  • 12.5. Latin America
    • 12.5.1. Argentina
    • 12.5.2. Brazil
    • 12.5.3. Rest of Latin America

13. Company Profile

  • 13.1. Merck KGaA
    • 13.1.1. Company details
    • 13.1.2. Financial outlook
    • 13.1.3. Product summary
    • 13.1.4. Recent developments
  • 13.2. Thermo Fisher Scientific Inc
    • 13.2.1. Company details
    • 13.2.2. Financial outlook
    • 13.2.3. Product summary
    • 13.2.4. Recent developments
  • 13.3. Bio-RAD Laboratories Inc
    • 13.3.1. Company details
    • 13.3.2. Financial outlook
    • 13.3.3. Product summary
    • 13.3.4. Recent developments
  • 13.4. Tecan Group Ltd
    • 13.4.1. Company details
    • 13.4.2. Financial outlook
    • 13.4.3. Product summary
    • 13.4.4. Recent developments
  • 13.5. Agilent Technologies Inc
    • 13.5.1. Company details
    • 13.5.2. Financial outlook
    • 13.5.3. Product summary
    • 13.5.4. Recent developments
  • 13.6. Hamilton Company
    • 13.6.1. Company details
    • 13.6.2. Financial outlook
    • 13.6.3. Product summary
    • 13.6.4. Recent developments
  • 13.7. Promega Corporation
    • 13.7.1. Company details
    • 13.7.2. Financial outlook
    • 13.7.3. Product summary
    • 13.7.4. Recent developments
  • 13.8. Illumina Inc
    • 13.8.1. Company details
    • 13.8.2. Financial outlook
    • 13.8.3. Product summary
    • 13.8.4. Recent developments
  • 13.9. Danaher
    • 13.9.1. Company details
    • 13.9.2. Financial outlook
    • 13.9.3. Product summary
    • 13.9.4. Recent developments
  • 13.10. Qiagen N.V
    • 13.10.1. Company details
    • 13.10.2. Financial outlook
    • 13.10.3. Product summary
    • 13.10.4. Recent developments
  • 13.11. Others

14. Conclusion

15. List of Abbreviations

16. Reference Links

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!